Faizan Farooque

Faizan Farooque

InvestorPlace Contributor

Expertise: Real estate investment trusts (REITs), SPACs, Cryptocurrencies

Education: BSc (Hons) Degree in Applied Accounting, Oxford Brookes University; Introduction to Data Analysis Using Excel, Rice University; Excel Skills for Business: Intermediate, Macquarie University

About Faizan
Faizan Farooque is a finance journalist who has reported on the latest trends in the stock market for many years. He helps people by providing advice about saving and investing and keeping up with what’s happening in the financial world.

Faizan is writing for InvestorPlace.com, GuruFocus, and TipRanks and has previously worked as a financial journalist and data analyst for S&P Global. He can analyze company filings from sources like SEC, FINRA, and others to help identify potential investment opportunities. Researching specific industries is also something he does to provide industry insight for clients.

Faizan deeply understands the market and how to read the financial tea leaves to anticipate where things are headed. His expertise gives readers an insider’s perspective on what’s happening in the finance world so they can make smart decisions.

Recent Articles

Palantir Stock Should Be Bought on Any Pullbacks

By Faizan Farooque, InvestorPlace Contributor

Although the long-term outlook of PLTR stock remains positive, its valuation currently looks excessive.

6 Penny Stocks to Part With Before They Crash and Burn

By Faizan Farooque, InvestorPlace Contributor

Investing in penny stocks is always fraught with risk. However, these companies have dubious business models making them even riskier.

Vinco Ventures Is Only for Investors With Extreme Risk Tolerance

By Faizan Farooque, InvestorPlace Contributor

BBIG is doing well because the stock deals with all the things millennials like. Despite its focus on tech, the real issue is sustainability.

Greenidge Generation Is a Cautious Buy After a Steep Post-Merger Drop

By Faizan Farooque, InvestorPlace Contributor

GREE stock is suffering from the inevitable post-merger dip. However, it will recover as Bitcoin continues to gain in both price and utility.

Novavax Looks Primed and Ready for a Vaccine Comeback

By Faizan Farooque, InvestorPlace Contributor

NVAX stock looks enticing now after falling steeply due to delays in FDA emergency approval as well as other manufacturing issues.

Load More